Evidence map›Paper›PMID 33227946›Full record

ArticleMarine drugs2020

Interaction of

Livan Delgado-Roche, Rebeca Santes-Palacios, José A Herrera, Sandra L Hernández, Mario Riera, Miguel D Fernández, Fernando Mesta, Gabino Garrido, Idania Rodeiro, Jesús Javier Espinosa-Aguirre

Open access · goldAbstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Marine drugs, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Livan Delgado-RocheDepartamento de Farmacología, Instituto de Ciencias del Mar (ICIMAR), Loma 14, Alturas del Vedado, Plaza de la Revolución, La Habana 10600, Cuba.
Rebeca Santes-PalaciosLaboratorio de Toxicología Genética, Instituto Nacional de Pediatría, Insurgentes Sur 3700, Insurgentes Cuicuilco, Ciudad de México 04530, Mexico.
José A HerreraInstituto de Ciencia y Tecnología de Materiales (IMRE), Universidad de La Habana, Zapata y G, Vedado, Plaza de la Revolución, La Habana 10400, Cuba.
Sandra L HernándezDepartamento de Medicina Genómica y Toxicología Ambiental, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (UNAM), Ciudad Universitaria, Ciudad de México 04510, Mexico.
Mario RieraDepartamento de Farmacología, Instituto de Ciencias del Mar (ICIMAR), Loma 14, Alturas del Vedado, Plaza de la Revolución, La Habana 10600, Cuba.
Miguel D FernándezDepartamento de Farmacología, Instituto de Ciencias del Mar (ICIMAR), Loma 14, Alturas del Vedado, Plaza de la Revolución, La Habana 10600, Cuba.
Fernando MestaEscuela Nacional de Medicina y Homeopatía, Instituto Politécnico Nacional, Guillermo Massieu Helguera 239, Ciudad de México 07320, Mexico.
Gabino GarridoDepartamento de Ciencias Farmacéuticas, Facultad de Ciencias, Universidad Católica del Norte, Angamos 0610, Antofagasta 1240000, Chile.ORCID 0000-0002-4547-4109
Idania RodeiroDepartamento de Farmacología, Instituto de Ciencias del Mar (ICIMAR), Loma 14, Alturas del Vedado, Plaza de la Revolución, La Habana 10600, Cuba.ORCID 0000-0002-2692-6050
Jesús Javier Espinosa-AguirreDepartamento de Medicina Genómica y Toxicología Ambiental, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (UNAM), Ciudad Universitaria, Ciudad de México 04510, Mexico.
Universidad Nacional Autónoma de México · MXInstituto Nacional de Pediatria · MXInstituto Politécnico Nacional · MXUniversidad Católica del Norte · CLUniversity of Havana · CU

Funding

Becas de Excelencia del Gobierno de México para Extranjeros SNCITMA P211LH005-019FONDECYT 1130601
6 · The paper itself

Abstract

The aim of the present work was to evaluate the effects of

Indexed as

Activation, MetabolicAnimalsAntimutagenic AgentsBenzo(a)pyreneCytochrome P-450 CYP1A1Cytochrome P-450 CYP1A2Cytochrome P-450 CYP1A2 InhibitorsCytochrome P-450 Enzyme InhibitorsDNA DamageFlavonoidsHumansHydrocharitaceaeIsoenzymesKineticsMicronuclei, Chromosome-DefectiveMicronucleus TestsAntimutagenic AgentsBenzo(a)pyreneCYP1A1 protein, humanCYP1A2 protein, humanCyp1a2 protein, ratCytochrome P-450 CYP1A1Cytochrome P-450 CYP1A2Cytochrome P-450 CYP1A2 InhibitorsCytochrome P-450 Enzyme InhibitorsFlavonoidsIsoenzymesPolyphenolsthalassiolin Bbenzo[a]pyrenechemopreventionCYP1A1polyphenolsThalassia testudinumthalassiolin B

Identifiers

PMID33227946
PMCPMC7699293
OpenAlexW3097067098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.